Evidence map›Paper›PMID 39872171›Full record

ArticleIn vitro models2023

Fracture mechanism and mechanical properties of porous HA/PLCL and HA/PLLA sandwich composite beams.

Fatin Hazwani, Aiman Izmin, Mitsugu Todo

Abstract read
In one paragraph

Article in In vitro models, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatin HazwaniDepartment of Biomedical Engineering, Institute of Global Innovation Research, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Aiman IzminInterdisciplinary Graduate School of Engineering Sciences, Kyushu University, Fukuoka, Japan.
Mitsugu TodoResearch Institute for Applied Mechanics, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we have developed a novel porous hydroxyapatite/poly l-lactic-co-caprolactone (HA/PLCL) composite sandwich beam as a new scaffold material for bone regeneration. This work presents the study of bending fracture mechanisms and microdamage of porous hydroxyapatite/poly L-lactic-acid (HA/PLLA) sandwich beam, in comparison to the previous developed HA/PLCL sandwich beam. Both beams were fabricated using the sandwich method in which the single porous composite beams were layered in between two porous polymer layers of their kind. Three-point bending tests were performed to assess their mechanical properties, and their microstructures along with the damage mechanisms were examined using field emission-scanning electron microscope (FE-SEM). Their crystalline structures and thermal properties were analyzed using Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD) analysis, and differential scanning calorimetry (DSC) measurements. The microdamage and fracture mechanisms were then characterized by stepwise crack formations. It was found that HA/PLLA composite sandwich beam possessed higher mechanical properties compared to HA/PLCL sandwich beam, resulting from higher stiffness of PLLA polymer. PLCL layer showed a vast ductile fracture, with elongated PLCL strips, while the fracture surfaces observed on the PLLA layer have a relatively brittle fracture pattern with some polymeric pores that were still visible. Three stages of damage were observed on both beams with different locations of crack initiation, indicating that different polymer materials do affect the fracture behavior of each beam.

Indexed as

Bending mechanical propertiesBiodegradable polymerPorous biomaterialsSandwich structure

Identifiers

PMID39872171
PMCPMC11756499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.